Connor, Clark & Lunn Investment Management Ltd.
Position in AGIO — Agios Pharmaceuticals, Inc.
CIK 1596800
VANCOUVER, A1
Position in AGIO
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$15,226,646
-$88,469 QoQ
Shares Held
450,093
-20.0% QoQ
Ownership
0.757%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AGIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Connor, Clark & Lunn Investment Management Ltd. holds $706,217,766 across 100 Biotechnology names. AGIO ranks #10 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
251,711 | $112,399,029 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
874,089 | $65,635,343 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
836,981 | $52,478,708 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
479,476 | $44,293,992 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
32,164 | $24,851,192 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
134,792 | $22,782,543 | |
| 7 | SRPT |
Sarepta Therapeutics, Inc.
|
1,019,951 | $22,194,133 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
384,681 | $20,280,382 |
All Filings in AGIO
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15,226,646 | 450,093 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $15,315,115 | 562,642 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $21,278,133 | 530,098 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $16,803,783 | 505,225 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $11,325,123 | 386,523 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $4,129,779 | 125,678 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $989,589 | 22,273 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $1,607,556 | 37,281 | Shares | Sole | 2024-08-09 | |
| 2023-12-31 | $225,617 | 10,131 | Shares | Sole | 2024-02-09 | |
| 2023-06-30 | $2,267,950 | 80,083 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $2,814,605 | 122,534 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $4,272,147 | 152,142 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $5,471,473 | 193,475 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $3,140,491 | 141,655 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $3,169,729 | 108,888 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,809,661 | 85,478 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $4,805,276 | 104,123 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,442,779 | 26,180 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $442,244 | 8,564 | Shares | Sole | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||